Every Thursday we send out a curated newsletter on “all things femtech and women’s health innovation”. This is the latest edition. If you’re interested in subscribing, you can do so at the bottom of this page.

Oviva Founder Dr. Daisy Robinton: “We’re uncovering novel insights into ovarian physiology to develop first-in-class therapeutics that improve ovarian function and prevent aging of the ovary. With this we hope to restore years of health and agency to women all over the world.”

Highlights

Women’s health biotech company Oviva raises $11.5M in seed funding to address ovarian aging.

Welcome! You\’ve found some of our exclusive Inner Circle Content. 

This article is only available for our Inner Circle Members. To read on: